SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-012766
Filing Date
2019-04-24
Accepted
2019-04-24 17:30:28
Documents
5
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A ovid-defa14a_20190424.htm DEFA14A 33473
2 GRAPHIC gijou0bjjuzs000002.jpg GRAPHIC 82424
3 GRAPHIC gijou0bjjuzs000003.jpg GRAPHIC 23585
4 GRAPHIC gijou0bjjuzs000001.jpg GRAPHIC 47196
5 GRAPHIC gijou0bjjuzs000004.jpg GRAPHIC 8716
  Complete submission text file 0001564590-19-012766.txt   258052
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38085 | Film No.: 19764726
SIC: 2834 Pharmaceutical Preparations